JONATHAN KOZIEL: Open Payments
NPI 1023595816 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 31 payments from 8 companies in 2025. Trend: 2023 $203 · 2024 $275 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 17 | $298 |
| Alkermes, Inc. | 3 | $170 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Indivior Inc. | 5 | $79 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Orexo US, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: BRIXADI, ABILIFY MAINTENA, LYBALVI, SUBLOCADE, ARISTADA, MAVYRET, CAPLYTA, Zubsolv.
Industry payments across MI — which companies pay providers there.
